Efficient Collaboration Earns High Praise: RayThera Honors Medicilon with “Excellent Partnership Award”

Preclinical CRO

On November 10, Dr. Gene Hung, Founder and Chief Scientific Officer of RayThera, Inc., visited Medicilon’s Nanhui campus to further strengthen strategic collaboration and recognize outstanding achievements. During the visit, RayThera presented Medicilon with the “Excellent Partnership Award”, the Chemistry FTE Team with the “Excellent Service Team Award”, and Dr. Zhu Du, Vice President of […]

Search Medicilon

Preclinical CRO

EFMC-ISMC 2026

Preclinical CRO

Medicilon Delivers One Stop Preclinical Support as Yizhong Pharma Secures NMPA Clinical Approval for YXC‑001 Tri‑functional Antibody Fusion Protein and YXC‑002 4th‑Generation EGFR Kinase Inhibitor

Preclinical CRO

4th SMC and AimedBio ADC Conference

Contact Medicilon

Name(Required)
Address(Required)